NCI
Get informed when a big investor buys or sells
+ FollowOvervalued by 1137.2% based on the discounted cash flow analysis.
| Market cap | $437,846.00 |
|---|---|
| Enterprise Value | $48.46 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.65 |
| Beta | -2.87 |
| Outstanding Shares | 508,000 |
| P/E Ratio | -6.76 |
|---|---|
| PEG | 2.26 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.42 |
| Enterprise Value to EBIT | 29.2 |
| Enterprise Value to Net Income | -120 |
| Total Debt to Enterprise | 1.04 |
| Debt to Equity | 0.89 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data